This study demonstrated the prognostic implications of tumor-infiltrating MDSCs, PD-1+/CD8+ TIL ratio, and PD-L1 expression in stromal immune cells and tumor cells in patients with locally advanced rectal cancer. This evidence concerns the gene PDCD1 and rectal cancer.